Publications by authors named "Elisei R"

Since laparoscopic surgery became the gold standard for colorectal procedures, specific skills are required to achieve good outcomes. The best way to acquire basic and advanced skills and reach the learning curve plateau is by using dedicated simulators: box-trainers, video-trainers and virtual reality simulators. Laparoscopic skills training outside the operating room is cost-beneficial, faster and safer, and does not harm the patient.

View Article and Find Full Text PDF

Background: When the histological examination indicates papillary thyroid carcinoma (PTC), there is no unanimity on the need to proceed with completion thyroidectomy (CT). This study aims to assess the histologic parameters that influenced the decision to perform CT.

Materials And Methods: This study included PTC patients who underwent thyroid lobectomy between 2019 and 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Fine-needle-aspiration-cytology (FNAC) is a safe and cost-effective method for assessing thyroid nodules, but indeterminate cytology (ITN) sometimes requires further diagnostic surgery.
  • Recent studies from Europe and the U.S. suggest that thyroid cancer (TC) behaves differently based on pre-surgical FNAC results, with ITN cases showing less aggressive characteristics compared to more suspicious diagnoses.
  • A commentary involving thyroid experts highlights the consistent finding that TC with ITN diagnosis has lower rates of complications and mutations, indicating a need to consider less aggressive treatment options for these patients.
View Article and Find Full Text PDF

Background: Differentiated thyroid carcinoma (DTC), mainly papillary (PTC), at low risk of recurrence is currently managed with active surveillance strategies or less aggressive surgeries. However, total thyroidectomy with I treatment is still performed both if these tumors are diagnosed before or occasionally after surgery. This real-life study aimed to evaluate the rate of biochemical, structural, and functional events in a large series of consecutive DTCs at low risk of recurrence treated by total thyroidectomy, but not with I, in a medium-long-term follow-up.

View Article and Find Full Text PDF

Thyroid nodules in pediatric patients are less common than in adults but show a higher malignancy rate. Accordingly, the management of thyroid nodules in pediatric patients is more complex the younger the patient is, needing careful evaluation by physicians. In adult patients, specific ultrasound (US) features have been associated with an increased risk of malignancy (ROM) in thyroid nodules.

View Article and Find Full Text PDF

Context: The active surveillance (AS) program for papillary thyroid carcinoma (≤ 1 cm) at low-risk (mPTC) showed a low percentage of progression.

Objective: The aim of this study was to find a molecular signature of cases that showed disease progression during AS, which would allow their early identification.

Methods: We performed next generation sequencing of 95 fine needle aspiration cytology specimens from cases prospectively enrolled in the AS program to analyze key somatic driver alterations or gene fusions implicated in PTC tumorigenesis.

View Article and Find Full Text PDF

Purpose: Aims of this study were to investigate the prevalence of TP53 and TERT mutations in Medullary Thyroid carcinoma (MTC) and their role in inducing aggressiveness in positive cases.

Methods: We performed a literature search in PubMed to identify studies investigating the prevalence of TERT and TP53 mutations in MTC. We also included data on MTC cases (n = 193) obtained at our center and unpublished.

View Article and Find Full Text PDF
Article Synopsis
  • A highly selective RET inhibitor called selpercatinib has shown significant effectiveness in treating advanced RET-mutant medullary thyroid cancer, despite having some side effects.
  • A 70-year-old patient experienced a rare side effect known as obliterative bronchiolitis (OB) while receiving the treatment, which led to inflammation and fibrosis in his lungs.
  • Although the patient developed OB, he still showed a partial response to the cancer treatment, indicating the need for careful consideration of the balance between managing side effects and the efficacy of ongoing cancer therapy.
View Article and Find Full Text PDF

Introduction: Image-guided invasive procedures on the liver require a steep learning curve to acquire the necessary skills. The best and safest way to achieve these skills is through hands-on courses that include simulations and phantoms of different complications, without any risks for patients. There are many liver phantoms on the market made of various materials; however, there are few multimodal liver phantoms, and only two are cast in a 3D-printed mold.

View Article and Find Full Text PDF

Objective: The aim of this study was to assess the clinical impact of hand-foot syndrome (HFS) during treatment with two multikinase inhibitors, sorafenib and lenvatinib, in a large group of patients with advanced thyroid cancer. Moreover, we looked for possible associations between HFS occurrence and clinical and pathological features.

Methods: We retrospectively evaluated 239 patients with advanced thyroid cancer: 165 treated with lenvatinib and 74 with sorafenib.

View Article and Find Full Text PDF

: Patients with liver pathology benefit from image-guided interventions. Training for interventional procedures is recommended to be performed on liver phantoms until a basic proficiency is reached. In the last 40 years, several attempts have been made to develop materials to mimic the imaging characteristics of the human liver in order to create liver phantoms.

View Article and Find Full Text PDF
Article Synopsis
  • The VERIFY study investigated the effectiveness of vandetanib in patients with advanced differentiated thyroid cancer that did not respond to radioiodine therapy, focusing on its safety and efficacy compared to a placebo in a randomized, double-blind phase III trial.
  • The trial involved 235 patients, divided equally to receive either vandetanib or a placebo, with the main goal of assessing progression-free survival (PFS), which was found to be 10.0 months for the vandetanib group versus 5.7 months for the placebo group.
  • Despite showing a longer PFS, the study did not find a significant overall survival (OS) benefit, and patients receiving vandetanib experienced more severe adverse events and deaths compared to those
View Article and Find Full Text PDF
Article Synopsis
  • - The uptake of prehabilitation in Europe is low despite evidence showing its effectiveness, mainly due to limited awareness, understanding, and infrastructure issues.
  • - The authors propose a new, comprehensive definition of prehabilitation and highlight differentiated thyroid cancer as particularly suitable for this approach.
  • - To enhance implementation, the authors suggest practical solutions like personalization of programs, raising awareness, proving effectiveness, expanding teams, leveraging networks, and applying lessons from COVID-19.
View Article and Find Full Text PDF

Introduction: The COVID-19 pandemic has limited the availability of healthcare resources for non-COVID patients and decreased elective surgeries, including thyroidectomy. Despite the prioritization of surgical procedures, it has been reported that thyroidectomy for thyroid cancer (TCa) was adversely impacted. We assessed the impact of the pandemic on the surgical activities of two high-volume referral centers.

View Article and Find Full Text PDF
Article Synopsis
  • - The article discusses advancements in using the CRISPR/Cas9 gene-editing system, specifically focusing on modifying a single-nucleotide polymorphism in human thyroid cells (Nthy-Ori).
  • - Two delivery methods (lentivirus and chemical lipids) and two strategies for creating double-strand breaks (DSB) were tested, one using standard Cas9 and another with a modified version that creates single-strand breaks (SSB).
  • - The findings suggest that using the double nickase approach is more effective for inserting genes in these cells, while the regular CRISPR/Cas9 system is better suited for knocking out genes by causing mutations.
View Article and Find Full Text PDF

Objective: IgG4-related disease (IgG4-RD) can involve many organs, including thyroid and orbital tissues. A link between IgG4, Graves' disease (GD) and Graves' orbitopathy (GO) has been proposed, but results are conflicting. Here we investigated the possible association between IgG4 and GO.

View Article and Find Full Text PDF

Herein, we present a misleading case of advanced papillary thyroid carcinoma with lung, node, and pleural metastases, initially diagnosed as metastatic lung adenocarcinoma with papillary features, based on the histological and immunohistochemical analysis of a pleural biopsy. Between August 2019 and August 2020, the patient received 2 ineffective lines of systemic therapy, including a first line of chemotherapy with cisplatin and pemetrexed, and a second line of immunotherapy with atezolizumab. Comprehensive genomic profiling by next-generation sequencing on the archival pleural biopsy revealed an NTRK1-TMP3 fusion and comutation of the TERT promoter, commonly found in papillary thyroid carcinoma.

View Article and Find Full Text PDF

Purpose: Surgery plays a key role in the treatment of thyroid cancer (TC) patients. Locally advanced cases, however, can require an extensive surgical approach with technical issues and a high risk of complications. In these cases, a multidisciplinary evaluation should be carried out to evaluate pros and cons.

View Article and Find Full Text PDF

Background: Thyroid carcinoma (TC) is the most common endocrine cancer, with papillary thyroid carcinoma (PTC) being the most common subtype. BRAF and RAS oncogene were characterized as the most frequently altered genes in PTC, with a strong association between genotype and histotype. The most common mutation in BRAF gene is V600E and is prevalent in classic and aggressive variants of PTC, while BRAF K601E mutation is the most common among the other rare BRAF mutations.

View Article and Find Full Text PDF

Background: Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric cancer, it is rare in childhood and adolescence. While tumor persistence and recurrence are not uncommon, mortality remains extremely low. Complications of treatment are however reported in up to 48% of the survivors.

View Article and Find Full Text PDF

Background: The effect of estrogen and beta-human chorionic gonadotropin on micropapillary thyroid carcinoma (mPTC) is not defined. Pregnancy and menopause could represent critical moments during active surveillance (AS) for women with mPTC.

Objective: To evaluate the effect of either pregnancy or menopause on growth of mPTCs on AS.

View Article and Find Full Text PDF

Background: Selpercatinib, a highly selective, potent RET inhibitor, has shown efficacy in advanced -mutant medullary thyroid cancer in a phase 1-2 trial, but its efficacy as compared with approved multikinase inhibitors is unclear.

Methods: We conducted a phase 3, randomized trial comparing selpercatinib as first-line therapy with the physician's choice of cabozantinib or vandetanib (control group). Eligible patients had progressive disease documented within 14 months before enrollment.

View Article and Find Full Text PDF

Background: Second 131I treatment is commonly performed in clinical practice in patients with differentiated thyroid cancer and biochemical incomplete or indeterminate response (BiR/InR) after initial treatment.

Objective: The objective of the is study is to evaluate the clinical impact of the second 131I treatment in BiR/InR patients and analyze the predictive factors for structural incomplete response (SiR).

Patients And Methods: One hundred fifty-three BiR/InR patients after initial treatment who received a second 131I treatment were included in the study.

View Article and Find Full Text PDF